Company Description
Stryker Corporation operates as a medical technology company.
The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies.
The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies.
This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
| Country | United States |
| Founded | 1941 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 26,700 |
| CEO | Kevin Lobo |
Contact Details
Address: 1941 Stryker Way Portage, Michigan 49002 United States | |
| Phone | 269 385 2600 |
| Website | stryker.com |
Stock Details
| Ticker Symbol | SYK |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000310764 |
| CUSIP Number | 863667101 |
| ISIN Number | US8636671013 |
| Employer ID | 38-1239739 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin A. Lobo | Chairman, Chief Executive Officer and President |
| Glenn S. Boehnlein CPA | Vice President and Chief Financial Officer |
| Viju S. Menon | Group President of Global Quality and Operations |
| J. Andrew Pierce | Group President of MedSurg and Neurotechnology |
| Spencer S. Stiles | Group President of Orthopaedics and Spine |
| William E. Berry Jr. | Vice President and Chief Accounting Officer |
| Robert C. Cohen | Chief Technology Officer and Vice President of Global Research & Development - Joint Replacement |
| Alan Douville | Vice President, Chief Information Officer and Chief Information Security Officer |
| Jason Beach | Vice President of Finance and Investor Relations |
| Robert S. Fletcher | Vice President and Chief Legal Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 3, 2024 | 25-NSE | Filing |
| Nov 15, 2024 | 144 | Filing |
| Nov 7, 2024 | 144 | Filing |
| Nov 5, 2024 | 144 | Filing |
| Oct 30, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Sep 17, 2024 | 144 | Filing |
| Sep 13, 2024 | 144 | Filing |
| Sep 12, 2024 | CERT | Certification by an exchange approving securities for listing |
| Sep 11, 2024 | 8-A12B | Registration of securities |